Hangkang Pharmaceutical

Hangkang Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and high-volume production of chemical drugs and finished dosages. The company is widely recognized for its strong portfolio in anti-infectives, having been a pioneer in the Chinese market for Erythromycin Cyclocarbonate. Beyond antibiotics, Hangkang Pharmaceutical manufactures treatments for endocrine disorders, cardiovascular diseases, and various anti-inflammatory conditions. The company operates modern, GMP-certified manufacturing facilities in Hangzhou and is a key subsidiary of the broader Hangkang Group. Its business model integrates both the production of active pharmaceutical ingredients (APIs) and the marketing of branded generic formulations for the domestic Chinese market.